Immediate Covid-19 Screening and Control of Airborne Spreading
SINHATECH, Oxford, Mississippi, United States
Detection technologies for identification of SARS-CoV-2 from environmental samples
Tech Brief: An inexpensive breathalyzer for screening Covid-19 infection within seconds is being developed based on recent evidence that infected individuals exhale detectably more small aerosol droplets. Our validated patented flow control concentrates aerosols into vortices on an electrically charged digitally imaged surface. Particle deposition density immediately detects possible Covid-19 infection.
Small to Medium Enterprise
FIGURES OF MERIT Value Proposition: Instantaneous non-intrusive screening of Covid-19 infected individuals enabled by our innovation will be key towards controlling airborne virus spreading in crowded and/or confined ventilation challenged environments where social distancing is difficult. Forehead temperature measurement is the only Instantaneous screening for Covid-19 available now. Competing existing and upcoming breathalyzer screening requires at least 10 minutes. We currently see an immediate $23 Million estimated market in instantaneous pre-board screening of 2.3 million (2019 data) US airline passengers since Covid-19 has reduced the number to 0.837 million in 2020.